000 01700 a2200421 4500
005 20250517235708.0
264 0 _c20200129
008 202001s 0 0 eng d
022 _a1557-3117
024 7 _a10.1016/j.healun.2018.07.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrost, Adaani E
245 0 0 _aRisk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score.
_h[electronic resource]
260 _bThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
_c12 2018
300 _a1410-1417 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xclassification
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhenylpropionates
_xtherapeutic use
650 0 4 _aPyridazines
_xtherapeutic use
650 0 4 _aRegistries
650 0 4 _aRisk Assessment
650 0 4 _aSurvival Rate
650 0 4 _aTadalafil
_xtherapeutic use
700 1 _aHoeper, Marius M
700 1 _aBarberá, Joan Albert
700 1 _aVachiery, Jean-Luc
700 1 _aBlair, Christiana
700 1 _aLangley, Jonathan
700 1 _aRubin, Lewis J
773 0 _tThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
_gvol. 37
_gno. 12
_gp. 1410-1417
856 4 0 _uhttps://doi.org/10.1016/j.healun.2018.07.001
_zAvailable from publisher's website
999 _c28829414
_d28829414